Total Voting Rights

Summary by AI BETAClose X

Hemogenyx Pharmaceuticals plc announced on 30 January 2026 that its total issued share capital comprises 6,041,255 ordinary shares of 1p each, with no shares held in treasury, resulting in a total of 6,041,255 voting rights. This figure serves as the denominator for shareholders to determine notification requirements under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules regarding their interests in the company's share capital.

Disclaimer*

UK 100

Latest directors dealings